Double blind placebo controlled trial of pizotifen syrup in the treatment of abdominal migraine.
- 1 January 1995
- journal article
- clinical trial
- Published by BMJ in Archives of Disease in Childhood
- Vol. 72 (1) , 48-50
- https://doi.org/10.1136/adc.72.1.48
Abstract
Fourteen children with abdominal migraine were treated with pizotifen and placebo in a double blind crossover trial. The results showed pizotifen to be clearly superior to placebo in the prophylaxis of abdominal migraine. The importance of clearly distinguishing abdominal migraine from other forms of recurrent abdominal pain is emphasised.Keywords
This publication has 15 references indexed in Scilit:
- Current Controversies Abdominal MigraineCephalalgia, 1993
- CLINICAL EPIDEMIOLOGY OF CHILDHOOD ABDOMINAL MIGRAINE IN AN URBAN GENERAL PRACTICEDevelopmental Medicine and Child Neurology, 1993
- Is there a place for "abdominal migraine" as a separate entity in the IHS classification? No!1992
- Is There a Place for “Abdominal Migraine” as a Separate Entity in the IHS Classification?Cephalalgia, 1992
- The VER as a Diagnostic Marker for Childhood Abdominal MigraineHeadache: The Journal of Head and Face Pain, 1990
- Visual evoked responses in children with migraine: a diagnostic testThe Lancet, 1990
- Abnormal gastroduodenal motility in children and adolescents with recurrent functional abdominal painThe Journal of Pediatrics, 1988
- Abdominal Migraine: A Childhood Syndrome DefinedCephalalgia, 1986
- Pizotifen (Sanomigran) in Childhood MigraineEuropean Neurology, 1986
- THE ABDOMINAL CRISES OF MIGRAINEJournal of Nervous & Mental Disease, 1921